Arrowhead Pharmaceuticals stock could remain under pressure in the near-term, but improved financial outlook and pipeline ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.Da3GqCks.js ...
Scientists comment on data published by Copernicus that shows January 2025 was the warmest on record globally. Dr Joel Hirschi, Associate Head of Marine Systems Modelling, UK’s National Oceanography ...
After weeks of negotiating with Barcelona, Manchester United forward Marcus Rashford eventually headed to Aston Villa on loan on deadline day. The Mancunian dropped a bombshell on the club when he ...
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
Diagnostic radiopharmaceuticals, including PYLARIFY ... The effect of these therapies on performance of PYLARIFY PET has not been established. To report suspected adverse reactions for PYLARIFY, call ...
A reinvigorated interest in radiopharmaceuticals has brought nuclear medicine to the foreground with deals over 2024 further exemplifying this trend. As revenues rose for Novartis ...
If there was no report of the adverse reaction in the progress notes, the provider was contacted to determine whether he or she knew about the reaction. If not, we then asked the provider if any ...
Background Adverse event surveillance approaches underestimate the ... We used descriptive statistics to report population estimates of harmful, preventable and severely harmful DEs by demographic ...
In this episode of Report in Short, Aaron Schwartzbaum speaks with Lieutenant Colonel Denys Yurchenko about his recent FPRI report, “Russian Strategic Culture and the War in Ukraine.“ In the report, ...
The detection of adverse drug reactions (ADRs) by a traditional passive reporting system and by a method involving patient and provider interviews was studied. The study sample consisted of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results